Gordon B. Mills, MD, PhD, Oral History Interview, May 23, 2016
Loading...
Description
Major Topics Covered:
- Personal background; educational path
- Professional path prior to MD Anderson
- Research areas: immunology, targeted therapy, interleukin-2, Women’s Cancer Moon Shot
- Institutional development: Department of Systems Biology, Kleberg Institute, Zayed Institute
Interview Chapters
Chapter 01: An Education Designed to Keep Options Open
Chapter 02: Medical School with a Path to Research and Team Science
Chapter 04: The Challenging Job Market for Researchers and for Team Scientists
Chapter 06: Recruited to MD Anderson; A History of Translational Research at MD Anderson
Identifier
MillsG_01_20160523
Publication Date
5-23-2016
Publisher
The Making Cancer History® Voices Oral History Collection, The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Topics Covered
University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center, University of Texas System. M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute at Houston, University of Texas M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute
Disciplines
History of Science, Technology, and Medicine | Oncology | Oral History
Recommended Citation
Mills, Gordon B. MD, PhD and Rosolowski, Tacey A. PhD, "Gordon B. Mills, MD, PhD, Oral History Interview, May 23, 2016" (2016). Interview Sessions. 12.
https://openworks.mdanderson.org/mchv_interviewsessions/12
Conditions Governing Access
Open
About the Interview
Gordon B. Mills, MD, PhD (b. 3 August 1953, Edmonton, Canada) was recruited to MD Anderson in 1994 to Chair the Department of Molecular Oncology and serve as Chief of the Section of Molecular Therapeutics. In 2006 he founded the first systems biology department focused on cancer in the US. He has served as Chair of the Department of Systems Biology [in the Division of Science] since that time. He has served as co-director of the Zayed Institute for Personalized Cancer Therapy, since 2010 and co-head of the Women's Cancer Moon Shot since 2013. Dr. Mills’ research focuses on the PI3K pathway, lysophospholipids, the genomics and genetics of women’s cancers, and identifying and characterizing a number of potential oncogenes and tumor suppressor genes.